| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | BMY Bristol Myers Squibb Co | Vessey Rupert53 | EVP, Research &Early Dev. | Sell | 19,298 | $61.99 | $1,196,252.03 | -20.0% | +13.0% | +21.9% | |
| Dec 16, 2021 | PRGO Perrigo Co Plc | Parker Geoffrey M.46 | Director | Buy | 5,000 | $36.85 | $184,270.00 | +85.0% | +4.0% | -12.3% | |
| Dec 16, 2021 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 27,000 | $11.28 | $304,560.00 | -7.8% | +10.1% | +8.1% | |
| Dec 16, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chirag K. | President &Co-ceo | Buy | 150,000 | $4.17 | $625,500.00 | +18.2% | -1.4% | -46.4% | |
| Dec 16, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Patel Chintu | Co-ceo | Buy | 150,000 | $4.17 | $625,500.00 | +18.2% | -1.4% | -46.4% | |
| Dec 15, 2021 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 205,000 | $271.90 | $55,739,338.42 | - | +0.5% | +32.6% | |
| Dec 15, 2021 | AMRX Amneal Pharmaceuticals, Inc. | Shah Nikita53 | Executive Vice President | Sell | 2,000 | $3.95 | $7,900.00 | -0.9% | -4.1% | -45.2% | |
| Dec 15, 2021 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 5,693 | $18.33 | $104,352.69 | -6.9% | -2.7% | +20.6% | |
| Dec 15, 2021 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 1,242 | $26.72 | $33,186.24 | -2.0% | +91.9% | +92.5% | |
| Dec 15, 2021 | AMRN Amarin Corp Plc\uk | Zakrzewski Joseph S55 | Director | Buy | 12,000 | $3.25 | $38,999.00 | +3.2% | -11.4% | -62.0% | |
| Dec 14, 2021 | HIMS Hims & Hers Health, Inc. | Abraham Jack | 10% Owner | Sell | 1,000,000 | $5.55 | $5,548,300.00 | -12.2% | -29.1% | +30.7% | |
| Dec 14, 2021 | IRWD Ironwood Pharmaceuticals Inc | McHugh Julie53 | Director | Sell | 10,000 | $11.02 | $110,200.00 | -6.7% | +6.6% | +13.6% | |
| Dec 13, 2021 | HIMS Hims & Hers Health, Inc. | Dudum Andrew48 | Chief Executive Officer | Buy | 81,100 | $5.93 | $480,712.14 | New | -33.8% | +24.8% | |
| Dec 13, 2021 | ORGO Organogenesis Holdings Inc. | Katz Michael W | 10% Owner | Buy | 500 | $9.65 | $4,825.00 | +0.8% | -24.0% | -71.9% | |
| Dec 10, 2021 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 5,291 | $21.36 | $113,006.24 | -10.5% | +41.8% | +32.1% | |
| Dec 9, 2021 | SIGA Siga Technologies Inc | Antal James | Director | Sell | 30,000 | $7.82 | $234,600.00 | -22.9% | -10.2% | +10.8% | |
| Dec 8, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 297,273 | $18.49 | $5,496,869.49 | -1.6% | +3.8% | +9.6% | |
| Dec 8, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 60,000 | $0.29 | $17,458.00 | - | - | - | |
| Dec 7, 2021 | JNJ Johnson & Johnson | Decker Robert J56 | Controller, CAO | Sell | 5,000 | $163.21 | $816,050.00 | -26.0% | +6.1% | +11.3% | |
| Dec 7, 2021 | BCRX Biocryst Pharmaceuticals Inc | Babu Yarlagadda S66 | Chief Discovery Officer | Sell | 30,100 | $12.20 | $367,220.00 | -12.3% | +42.2% | -12.2% | |
| Dec 7, 2021 | ANIP Ani Pharmaceuticals Inc | Pera Antonio R58 | Director | Buy | 3,000 | $42.26 | $126,793.50 | +18.0% | -14.2% | -10.1% | |
| Dec 6, 2021 | PRGO Perrigo Co Plc | Andersen Svend47 | EVP &President Chci | Buy | 3,655 | $37.10 | $135,599.40 | +16.3% | -1.8% | -11.8% | |
| Dec 6, 2021 | ANIP Ani Pharmaceuticals Inc | Haughey Thomas | Director | Buy | 2,500 | $39.38 | $98,450.00 | +9.0% | -10.5% | -7.1% | |
| Dec 6, 2021 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Sell | 110,209 | $18.10 | $1,994,529.59 | -0.8% | +8.8% | +9.0% | |
| Dec 3, 2021 | PFE Pfizer Inc | Johnson Rady A | Executive Vice President | Sell | 19,000 | $53.42 | $1,015,041.96 | -2.4% | -11.2% | -3.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.